[Objectives]To explore the intervention effect of the representative formula of Xinrun Tongluo method,Liangxue Xiaofeng Powder,on the incidence of androgenic alopecia in the syndrome of blood heat and wind dryness.[Me...[Objectives]To explore the intervention effect of the representative formula of Xinrun Tongluo method,Liangxue Xiaofeng Powder,on the incidence of androgenic alopecia in the syndrome of blood heat and wind dryness.[Methods]A total of 72 patients with androgenic alopecia in Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine from October,2022 to June,2023 were randomly divided into a control group(36 cases,treated with Western medicine)and a treatment group(36 cases,treated with Chinese herbal formula+Western medicine).The short-term and long-term efficacy of the two groups of patients was compared.[Results]The hair microscopic signs and short-term and long-term efficacy of the treatment group were significantly better than those of the control group before and after treatment,with a statistically significant difference(P<0.05).[Conclusions]The representative formula of Xinrun Tongluo method is Liangxue Xiaofeng Powder,which has better clinical efficacy as an auxiliary Western medicine in the treatment of androgenic alopecia patients with blood heat and wind dryness syndrome,and is worthy of further promotion and application in clinical practice.展开更多
目的观察当归止痒方治疗成人血虚风燥型特应性皮炎的临床疗效及安全性。方法2021年7月—2022年1月该院皮肤科就诊的成人特应性皮炎患者中纳入符合血虚风燥证型患者,共76例。随机分入试验组和对照组,每组38例。对照组口服润燥止痒胶囊,...目的观察当归止痒方治疗成人血虚风燥型特应性皮炎的临床疗效及安全性。方法2021年7月—2022年1月该院皮肤科就诊的成人特应性皮炎患者中纳入符合血虚风燥证型患者,共76例。随机分入试验组和对照组,每组38例。对照组口服润燥止痒胶囊,试验组口服当归止痒方,两组皆外用纽强倍润型润肤露。治疗8周,对两组瘙痒面积及严重度指数(Eczema Area and Severity Index,EASI)评分、患者主观湿疹评分(Patient-Oriented Eczema Measure,POEM)评分、皮肤病患者生活质量量表(Dermatology Life Quality Index,DLQI)评分、研究者整体评估(Investigator′s Global Assessment,IGA)评分、瘙痒数值评分(Itch-Numerical Rating Scores,Itch-NRS)评分、血清总IgE、血清嗜酸性粒细胞计数(EOS)、中医症状积分及安全性指标等方面进行评价。结果(1)试验组总有效率91.89%(34/37),高于对照组61.76%(21/34)(P<0.05);试验组中医症状积分改善有效率86.49%(32/37),高于对照组47.05%(16/34)(P<0.05)。(2)试验组EASI评分(17.81±6.06)分、POEM评分(11.19±3.76)分、DLQI评分(14.16±3.03)分、IGA评分(2.24±0.68)分、Itch-NRS评分(4.73±1.37)分的下降均较对照组明显(P均<0.05)。(3)两组血清EOS水平在治疗后均有所下降(P<0.05);血清IgE水平两组均无明显干预效果。结论当归止痒方治疗成人血虚风燥型特应性皮炎的临床疗效显著优于润燥止痒胶囊,没有使用首乌的情况下也能够有效改善患者瘙痒症状,提高患者生活质量,同时能够改善患者血虚、便秘、皮肤干燥、瘙痒等中医伴随症状,且没有不良反应发生。展开更多
目的观察针刺、刺血疗法配合徐长卿合剂治疗慢性自发性荨麻疹血虚风燥证的临床疗效及其对免疫球蛋白E(immunoglobulin E,IgE)、嗜酸性粒细胞(eosinophils,EOS)水平的影响。方法将83例慢性自发性荨麻疹血虚风燥证患者随机分为治疗组(42例...目的观察针刺、刺血疗法配合徐长卿合剂治疗慢性自发性荨麻疹血虚风燥证的临床疗效及其对免疫球蛋白E(immunoglobulin E,IgE)、嗜酸性粒细胞(eosinophils,EOS)水平的影响。方法将83例慢性自发性荨麻疹血虚风燥证患者随机分为治疗组(42例)和对照组(41例)。治疗组采用针刺、刺血疗法配合徐长卿合剂口服治疗,对照组采用口服盐酸左西替利嗪片治疗。观察两组治疗前后1周荨麻疹活动度(urticaria activity score over 7 days,UAS7)、皮肤病生活质量指数(dermatology life quality index,DLQI)、荨麻疹控制程度测试(urticaria control test,UCT)评分、血清IgE水平、血EOS百分比及绝对值的变化情况,并比较两组临床疗效。结果两组治疗后UAS7各项评分、DLQI评分及血清IgE水平均较同组治疗前显著下降,UCT评分显著上升,差异均有统计学意义(P<0.05)。治疗组治疗后UAS7各项评分、DLQI评分、UCT评分及血清IgE水平与对照组比较,差异均有统计学意义(P<0.05)。两组治疗后血EOS百分比、绝对值组内及组间比较,差异均无统计学意义(P>0.05)。治疗组总有效率为95.0%,明显高于对照组的80.0%(P<0.05)。结论针刺、刺血疗法配合徐长卿合剂治疗慢性自发性荨麻疹血虚风燥证疗效确切,能下调IgE、EOS水平,改善患者生活质量及免疫状态。展开更多
基金Supported by Suzhou Science and Technology Development Plan project (SKYD2022141)The Ninth Batch of Suzhou Gusu Health Key Talents Project (GSWS2022107).
文摘[Objectives]To explore the intervention effect of the representative formula of Xinrun Tongluo method,Liangxue Xiaofeng Powder,on the incidence of androgenic alopecia in the syndrome of blood heat and wind dryness.[Methods]A total of 72 patients with androgenic alopecia in Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine from October,2022 to June,2023 were randomly divided into a control group(36 cases,treated with Western medicine)and a treatment group(36 cases,treated with Chinese herbal formula+Western medicine).The short-term and long-term efficacy of the two groups of patients was compared.[Results]The hair microscopic signs and short-term and long-term efficacy of the treatment group were significantly better than those of the control group before and after treatment,with a statistically significant difference(P<0.05).[Conclusions]The representative formula of Xinrun Tongluo method is Liangxue Xiaofeng Powder,which has better clinical efficacy as an auxiliary Western medicine in the treatment of androgenic alopecia patients with blood heat and wind dryness syndrome,and is worthy of further promotion and application in clinical practice.
文摘目的观察当归止痒方治疗成人血虚风燥型特应性皮炎的临床疗效及安全性。方法2021年7月—2022年1月该院皮肤科就诊的成人特应性皮炎患者中纳入符合血虚风燥证型患者,共76例。随机分入试验组和对照组,每组38例。对照组口服润燥止痒胶囊,试验组口服当归止痒方,两组皆外用纽强倍润型润肤露。治疗8周,对两组瘙痒面积及严重度指数(Eczema Area and Severity Index,EASI)评分、患者主观湿疹评分(Patient-Oriented Eczema Measure,POEM)评分、皮肤病患者生活质量量表(Dermatology Life Quality Index,DLQI)评分、研究者整体评估(Investigator′s Global Assessment,IGA)评分、瘙痒数值评分(Itch-Numerical Rating Scores,Itch-NRS)评分、血清总IgE、血清嗜酸性粒细胞计数(EOS)、中医症状积分及安全性指标等方面进行评价。结果(1)试验组总有效率91.89%(34/37),高于对照组61.76%(21/34)(P<0.05);试验组中医症状积分改善有效率86.49%(32/37),高于对照组47.05%(16/34)(P<0.05)。(2)试验组EASI评分(17.81±6.06)分、POEM评分(11.19±3.76)分、DLQI评分(14.16±3.03)分、IGA评分(2.24±0.68)分、Itch-NRS评分(4.73±1.37)分的下降均较对照组明显(P均<0.05)。(3)两组血清EOS水平在治疗后均有所下降(P<0.05);血清IgE水平两组均无明显干预效果。结论当归止痒方治疗成人血虚风燥型特应性皮炎的临床疗效显著优于润燥止痒胶囊,没有使用首乌的情况下也能够有效改善患者瘙痒症状,提高患者生活质量,同时能够改善患者血虚、便秘、皮肤干燥、瘙痒等中医伴随症状,且没有不良反应发生。
文摘目的观察针刺、刺血疗法配合徐长卿合剂治疗慢性自发性荨麻疹血虚风燥证的临床疗效及其对免疫球蛋白E(immunoglobulin E,IgE)、嗜酸性粒细胞(eosinophils,EOS)水平的影响。方法将83例慢性自发性荨麻疹血虚风燥证患者随机分为治疗组(42例)和对照组(41例)。治疗组采用针刺、刺血疗法配合徐长卿合剂口服治疗,对照组采用口服盐酸左西替利嗪片治疗。观察两组治疗前后1周荨麻疹活动度(urticaria activity score over 7 days,UAS7)、皮肤病生活质量指数(dermatology life quality index,DLQI)、荨麻疹控制程度测试(urticaria control test,UCT)评分、血清IgE水平、血EOS百分比及绝对值的变化情况,并比较两组临床疗效。结果两组治疗后UAS7各项评分、DLQI评分及血清IgE水平均较同组治疗前显著下降,UCT评分显著上升,差异均有统计学意义(P<0.05)。治疗组治疗后UAS7各项评分、DLQI评分、UCT评分及血清IgE水平与对照组比较,差异均有统计学意义(P<0.05)。两组治疗后血EOS百分比、绝对值组内及组间比较,差异均无统计学意义(P>0.05)。治疗组总有效率为95.0%,明显高于对照组的80.0%(P<0.05)。结论针刺、刺血疗法配合徐长卿合剂治疗慢性自发性荨麻疹血虚风燥证疗效确切,能下调IgE、EOS水平,改善患者生活质量及免疫状态。
